April 21, 2026
The peptide-based weight loss medication market is expanding due to a growing health-conscious population as well as rising muscle-preserving weight loss medications. North America led the market due to the presence of a well-developed healthcare sec...
April 21, 2026
According to forecasts, the global peptide receptor radionuclide therapy market will grow from USD 2.34 billion in 2024 to USD 6.1 billion by 2034, with an expected CAGR of 10.06%. In 2024, North America led the global peptide receptor radionuclide t...
April 13, 2026
Peptide Therapeutics Market(By Type: Branded Peptide Drugs, Generic Peptide Drugs, By Route of Administration: Parenteral, Oral, Transdermal & Others, By Application/Therapeutic: Area Oncology, Metabolic Disorders, Infectious Diseases, Cardiov...
April 21, 2026
Market insights predict, the peptide synthesis industry is expected to grow from USD 686.59 million in 2024 to USD 2277.59 million by 2034, driven by a CAGR of 12.74%. The rising incidences of chronic disorders, growing research and development, and ...
April 21, 2026
Based on market forecasts, the biosynthesis peptide drugs sector will expand from USD 18.31 billion in 2024 to USD 32.88 billion by 2034, experiencing a CAGR of 6.26%. The biosynthesis peptide drugs market is growing, as these drugs offer many advant...
April 21, 2026
The chemical synthesis peptide drugs market is valued at US$ 2.74 billion in 2025 and is projected to reach US$ 4.82 billion by 2034, growing at a CAGR of 6.54%. Key segments include synthesis methods (chemical, non-chemical), technologies (SPPS, LPP...
April 21, 2026
Projections indicate that, GMP peptides industry is projected to rise from USD 1.3 billion in 2024 to USD 2.9 billion by 2034, reflecting a CAGR of 8.35% over the next decade. The growing demand for peptide drugs and technological advancements drives...
April 21, 2026
According to forecasts, the global collagen and gelatin market will grow from USD 1.25 billion in 2024 to USD 2.2 billion by 2034, with an expected CAGR of 5.84%. The market is growing due to rising consumer demand for clean-label, protein-rich sup...
April 21, 2026
According to market projections, the oral proteins & peptides sector is expected to grow from USD 8.05 billion in 2024 to USD 36.35 billion by 2034, reflecting a CAGR of 16.34%. A rise in R&D investments and patient preference is boosting t...